Page last updated: 2024-10-27

fluphenazine and Obesity

fluphenazine has been researched along with Obesity in 2 studies

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research Excerpts

ExcerptRelevanceReference
"Obesity is associated with increased morbidity and may reduce compliance, leading to a return of psychotic symptoms."1.27Prevalence of obesity in patients receiving depot antipsychotics. ( Goodall, E; Silverstone, T; Smith, G, 1988)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Silverstone, T1
Smith, G1
Goodall, E1
Gonzalez, JR1

Other Studies

2 other studies available for fluphenazine and Obesity

ArticleYear
Prevalence of obesity in patients receiving depot antipsychotics.
    The British journal of psychiatry : the journal of mental science, 1988, Volume: 153

    Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Female; Flupenthixol; Fluphenazine; Humans

1988
Extreme sensitivity to phenothiazines in a psychotic patient with Pickwick syndrome.
    The American journal of psychiatry, 1966, Volume: 122, Issue:9

    Topics: Adolescent; Brain Stem; Chlorpromazine; Fluphenazine; Humans; Intellectual Disability; Male; Obesity

1966